Amanat Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
Last trade$10.10
Day change-$0.005 (-0.05%)
Day range$10.08 – $10.13
Volume114,169
Market cap$98M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for AMAN.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for AMAN.
Recent news
Company coverage with links to the original publishers.
Corxel US, a clinical-stage biopharmaceutical company, has announced a definitive business combination agreement with Amanat Acquisition Corp (Nasdaq: AMAN) to become a publicly traded obesity-focused company. The transaction is expected to provide approximately $377 million in gross proceeds, with $300 million from a PIPE financing backed by prominent healthcare investors. The combined company will advance CX11, a once-daily oral GLP-1 receptor agonist that demonstrated clinically meaningful weight loss in Phase 2 trials, and CX12, an oral amylin receptor agonist. The transaction is expected to close in the first half of 2027.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.